Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The Cosmetic Ingredient Review’s newly figured margins of safety for single- and multi-paraben use in cosmetic products are dramatically lower than previous MOSs that informed the Expert Panel’s 2008 “safe as used” conclusions. Whether the panel still deems the MOSs sufficiently protective is the question going into the group’s Sept. 24-25 meeting.
Marketers' websites and product labels stated other noncompliant claims that render their products unapproved new drugs, but references to opioid withdrawal treatment got FDA Commissioner Scott Gottlieb's attention. "Despite our warnings and previous regulatory and enforcement actions, we continue to find marketers actively selling kratom with unsubstantiated claims," Gottlieb says.
Latest From Cosmetic Ingredients
The e-commerce giants should keep pace with regulatory notifications regarding mercury-containing cosmetics, implementing their restricted products policies accordingly, and require approval of skin-lightening products prior to sale, according to a coalition of 51 NGOs. They point to recent testing that found skin creams on Amazon.com and eBay.com to contain mercury at levels up to 30,000 ppm.
EU’s SCCS Reissues Guidance On Cosmetic Ingredient Testing With Updated Non-Animal Method Perspectives
The Scientific Committee on Consumer Safety’s guidance offers perspective on new approach methodologies that can be used to substantiate cosmetic ingredient safety, as well as areas where alternative strategies continue to be insufficient. The document also includes updated criteria for multi-constituent natural ingredients at a time of increasing industry use.
The agency will accept public comment for 60 days on its proposed survey to gain insight into “consumer use of cosmetic products, the frequency of adverse events believed to be caused by allergens in cosmetics, consumer awareness of the problem, and actions (if any) taken to avoid the allergens.”
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.